<p>Brucke Financial Inc. 在最近向證券交易委員會提交的 13F 文件中表示，在第四季度購買了 UnitedHealth Group Incorporated (NYSE:UNH - 免費報告) 的新股份。該公司購買了 907 股該醫療保健集團的股票，價值約為 492,000 美元。</p>
<p>獲取 <strong>UnitedHealth Group</strong> 警報：</p>
<ul>
<li>國會議員目前正在進行的 3 筆交易</li>
</ul>
<p>其他一些機構投資者和對沖基金最近也增加或減少了對該公司的持股。Waycross Partners LLC 在第四季度將其在 UnitedHealth Group 的股份提高了 2.4%。Waycross Partners LLC 現在擁有 27,794 股該醫療保健集團的股票，價值 14,060,000 美元，此前在上個季度又購買了 658 股。Sherbrooke Park Advisers LLC 在第四季度購買了 UnitedHealth Group 的新股份，價值約為 515,000 美元。Full Sail Capital LLC 在第四季度將其在 UnitedHealth Group 的股份提高了 2.1%。Full Sail Capital LLC 現在擁有 1,612 股該醫療保健集團的股票，價值 815,000 美元，此前在上個季度又購買了 33 股。索羅斯基金管理公司在第四季度購買了 UnitedHealth Group 的新股份，價值約為 39,413,000 美元。最後，Silvercrest Asset Management Group LLC 在第四季度將其在 UnitedHealth Group 的持股增加了 47.8%。Silvercrest Asset Management Group LLC 現在擁有 38,796 股該醫療保健集團的股票，價值 19,625,000 美元，此前在上個季度又購買了 12,550 股。機構投資者持有該公司 87.86% 的股份。</p>
<h2>內部活動</h2>
<p>在其他新聞中，董事 Kristen Gil 於 5 月 15 日星期四收購了 3,700 股 UnitedHealth Group 股票。該股票的平均購買成本為每股 271.17 美元，總價值為 1,003,329.00 美元。購買後，該董事現在擁有 3,818 股公司股票，價值 1,035,327.06 美元。這筆交易代表了他們持股的 3,135.59% 的增長。該購買在向證券交易委員會的文件中披露，相關信息可通過 SEC 網站獲取。此外，董事 Timothy Patrick Flynn 於 5 月 14 日星期三收購了 1,533 股 UnitedHealth Group 股票。該股票的平均購買成本為每股 320.80 美元，總價值為 491,786.40 美元。完成購買後，該董事現在擁有 6,033 股公司股票，價值 1,935,386.40 美元。這筆交易使其持股增加了 34.07%。該購買的披露信息可以在這裏找到。內部人士在上個季度收購了價值 31,607,768 美元的 109,408 股公司股票。公司內部人士持有該公司 0.33% 的股份。</p>
<h2>華爾街分析師預測增長</h2>
<ul>
<li>在 UnitedHealth 的拋售後，Hims &amp; Hers 股票會好嗎？</li>
</ul>
<p>一些研究分析師最近對 UNH 股票發表了看法。Wolfe Research 將 UnitedHealth Group 的目標價格從 501.00 美元下調至 390.00 美元，並在 5 月 20 日星期二的報告中對該公司給予了 “跑贏大盤” 的評級。瑞穗證券將 UnitedHealth Group 的目標價格從 515.00 美元下調至 350.00 美元，並在 5 月 16 日星期五的研究報告中對該公司給予了 “跑贏大盤” 的評級。Argus 在 4 月 21 日星期一的研究報告中將 UnitedHealth Group 的評級從 “買入” 下調至 “持有”。美國銀行在 5 月 14 日星期三的研究報告中將 UnitedHealth Group 的評級從 “買入” 下調至 “中性”，並將該股票的目標價格從 560.00 美元下調至 350.00 美元。最後，滙豐全球研究在 5 月 21 日星期三的研究報告中將 UnitedHealth Group 的評級從 “持有” 下調至 “適度賣出”。一位投資分析師對該股票給予了賣出評級，七位給予了持有評級，十七位給予了買入評級，還有一位給予了強烈買入評級。根據 MarketBeat 的數據，該股票的平均評級為 “適度買入”，平均目標價格為 441.87 美元。</p>
<p><strong>查看我們對 UnitedHealth Group 的最新分析</strong></p>
<h2>UnitedHealth Group 價格表現</h2>
<ul>
<li>UnitedHealth 內部人士加碼：UNH 股票是價值投資嗎？</li>
</ul>
<p>NYSE UNH 股票在週一開盤時為 295.37 美元。UnitedHealth Group Incorporated 的 52 周低點為 248.88 美元，52 周高點為 630.73 美元。該公司的市值為 2679.4 億美元，市盈率為 19.06，市盈增長比率為 1.37，貝塔係數為 0.56。該公司的速動比率為 0.91，流動比率為 0.83，債務與股本比率為 0.74。該業務的 50 日移動平均價格為 452.40 美元，200 日移動平均價格為 503.72 美元。</p>
<p>UnitedHealth Group (NYSE:UNH - 獲取免費報告) 最近於 4 月 17 日星期四公佈了其財報。該醫療保健集團報告的每股收益 (EPS) 為 7.20 美元，低於分析師一致預期的 7.29 美元，差額為 0.09 美元。UnitedHealth Group 的淨利潤率為 3.60%，股本回報率為 26.69%。該業務的季度收入為 1,095.8 億美元，而分析師的預期為 1,115.6 億美元。去年同期，該業務的每股收益為 6.91 美元。平均而言，賣方分析師預計 UnitedHealth Group Incorporated 在當前年度將發佈 29.54 美元的每股收益。</p>
<h2>UnitedHealth Group 簡介</h2>
<p>(免費報告)</p>
<p>聯合健康集團在美國作為一家多元化的醫療保健公司運營。該公司通過四個部門運營：聯合健康保險、Optum Health、Optum Insight 和 Optum Rx。聯合健康保險部門為國家僱主、公共部門僱主、中型僱主、小型企業和個人提供面向消費者的健康福利計劃和服務；為 50 歲及以上的個人提供醫療保險和健康與福祉服務，以滿足他們的需求；醫療補助計劃、兒童健康保險和醫療保健項目；以及健康和牙科福利、醫院和臨牀服務，以及為照顧經濟困難、醫療服務不足和沒有僱主資助醫療保險覆蓋的人羣的州項目提供的醫療保健福利產品和服務。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票超過聯合健康集團</li>
<li>投資商品：它們是什麼？如何投資？</li>
<li>這次市場拋售可能會觸發對百事可樂的價值輪換</li>
<li>複利及其在投資中的重要性</li>
<li>字母表股票滯後——但 Waymo 可能是其隱藏的驅動因素</li>
<li>低市盈率成長股：解鎖投資機會</li>
<li>Trade Desk 駁斥批評；復甦看起來有望繼續</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在聯合健康集團嗎？</h2>
<p>在你考慮聯合健康集團之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而聯合健康集團並不在名單上。</p>
<p>雖然聯合健康集團目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

聯合健康

<p>Brucke Financial Inc. 在第四季度收購了聯合健康（NYSE:UNH）的新頭寸，購買了 907 股，價值約為 492,000 美元。其他機構投資者也增加了對該公司的持股。值得注意的是，內部人士進行了大量購買，董事 Kristen Gil 購買了 3,700 股，董事 Timothy Patrick Flynn 購買了 1,533 股。分析師最近調整了對 UNH 的目標價格，評級範圍從 “強烈買入” 到 “賣出”。該股票開盤價為 295.37 美元，市值為 2679.4 億美元</p>

<p>Brucke Financial Inc. bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 907 shares of the healthcare conglomerate's stock, valued at approximately $492,000.</p>
<div class="lb-trans"><p>Brucke Financial Inc. 在最近向證券交易委員會提交的 13F 文件中表示，在第四季度購買了 UnitedHealth Group Incorporated (NYSE:UNH - 免費報告) 的新股份。該公司購買了 907 股該醫療保健集團的股票，價值約為 492,000 美元。</p>
</div><p>Get <strong>UnitedHealth Group</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>UnitedHealth Group</strong> 警報：</p>
</div><ul>
<li>3 Trades Members of Congress Are Making Right Now</li>
</ul>
<div class="lb-trans"><ul>
<li>國會議員目前正在進行的 3 筆交易</li>
</ul>
</div><p>A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Waycross Partners LLC raised its position in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after buying an additional 658 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $515,000. Full Sail Capital LLC raised its position in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after buying an additional 33 shares during the last quarter. Soros Fund Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $39,413,000. Finally, Silvercrest Asset Management Group LLC grew its holdings in shares of UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock valued at $19,625,000 after purchasing an additional 12,550 shares in the last quarter. Institutional investors own 87.86% of the company's stock.</p>
<div class="lb-trans"><p>其他一些機構投資者和對沖基金最近也增加或減少了對該公司的持股。Waycross Partners LLC 在第四季度將其在 UnitedHealth Group 的股份提高了 2.4%。Waycross Partners LLC 現在擁有 27,794 股該醫療保健集團的股票，價值 14,060,000 美元，此前在上個季度又購買了 658 股。Sherbrooke Park Advisers LLC 在第四季度購買了 UnitedHealth Group 的新股份，價值約為 515,000 美元。Full Sail Capital LLC 在第四季度將其在 UnitedHealth Group 的股份提高了 2.1%。Full Sail Capital LLC 現在擁有 1,612 股該醫療保健集團的股票，價值 815,000 美元，此前在上個季度又購買了 33 股。索羅斯基金管理公司在第四季度購買了 UnitedHealth Group 的新股份，價值約為 39,413,000 美元。最後，Silvercrest Asset Management Group LLC 在第四季度將其在 UnitedHealth Group 的持股增加了 47.8%。Silvercrest Asset Management Group LLC 現在擁有 38,796 股該醫療保健集團的股票，價值 19,625,000 美元，此前在上個季度又購買了 12,550 股。機構投資者持有該公司 87.86% 的股份。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部活動</h2>
</div><p>In other news, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 in the last quarter. Corporate insiders own 0.33% of the company's stock.</p>
<div class="lb-trans"><p>在其他新聞中，董事 Kristen Gil 於 5 月 15 日星期四收購了 3,700 股 UnitedHealth Group 股票。該股票的平均購買成本為每股 271.17 美元，總價值為 1,003,329.00 美元。購買後，該董事現在擁有 3,818 股公司股票，價值 1,035,327.06 美元。這筆交易代表了他們持股的 3,135.59% 的增長。該購買在向證券交易委員會的文件中披露，相關信息可通過 SEC 網站獲取。此外，董事 Timothy Patrick Flynn 於 5 月 14 日星期三收購了 1,533 股 UnitedHealth Group 股票。該股票的平均購買成本為每股 320.80 美元，總價值為 491,786.40 美元。完成購買後，該董事現在擁有 6,033 股公司股票，價值 1,935,386.40 美元。這筆交易使其持股增加了 34.07%。該購買的披露信息可以在這裏找到。內部人士在上個季度收購了價值 31,607,768 美元的 109,408 股公司股票。公司內部人士持有該公司 0.33% 的股份。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><ul>
<li>Will Hims &amp; Hers Stock Be Okay After UnitedHealth's Sell-Off?</li>
</ul>
<div class="lb-trans"><ul>
<li>在 UnitedHealth 的拋售後，Hims &amp; Hers 股票會好嗎？</li>
</ul>
</div><p>A number of research analysts recently weighed in on UNH shares. Wolfe Research cut their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an &#34;outperform&#34; rating for the company in a report on Tuesday, May 20th. Mizuho dropped their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an &#34;outperform&#34; rating for the company in a research note on Friday, May 16th. Argus lowered shares of UnitedHealth Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Monday, April 21st. Bank of America lowered shares of UnitedHealth Group from a &#34;buy&#34; rating to a &#34;neutral&#34; rating and dropped their price objective for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a &#34;hold&#34; rating to a &#34;moderate sell&#34; rating in a research note on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and an average price target of $441.87.</p>
<div class="lb-trans"><p>一些研究分析師最近對 UNH 股票發表了看法。Wolfe Research 將 UnitedHealth Group 的目標價格從 501.00 美元下調至 390.00 美元，並在 5 月 20 日星期二的報告中對該公司給予了 “跑贏大盤” 的評級。瑞穗證券將 UnitedHealth Group 的目標價格從 515.00 美元下調至 350.00 美元，並在 5 月 16 日星期五的研究報告中對該公司給予了 “跑贏大盤” 的評級。Argus 在 4 月 21 日星期一的研究報告中將 UnitedHealth Group 的評級從 “買入” 下調至 “持有”。美國銀行在 5 月 14 日星期三的研究報告中將 UnitedHealth Group 的評級從 “買入” 下調至 “中性”，並將該股票的目標價格從 560.00 美元下調至 350.00 美元。最後，滙豐全球研究在 5 月 21 日星期三的研究報告中將 UnitedHealth Group 的評級從 “持有” 下調至 “適度賣出”。一位投資分析師對該股票給予了賣出評級，七位給予了持有評級，十七位給予了買入評級，還有一位給予了強烈買入評級。根據 MarketBeat 的數據，該股票的平均評級為 “適度買入”，平均目標價格為 441.87 美元。</p>
</div><p><strong>View Our Latest Analysis on UnitedHealth Group</strong></p>
<div class="lb-trans"><p><strong>查看我們對 UnitedHealth Group 的最新分析</strong></p>
</div><h2>UnitedHealth Group Price Performance</h2>
<div class="lb-trans"><h2>UnitedHealth Group 價格表現</h2>
</div><ul>
<li>UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?</li>
</ul>
<div class="lb-trans"><ul>
<li>UnitedHealth 內部人士加碼：UNH 股票是價值投資嗎？</li>
</ul>
</div><p>Shares of NYSE UNH opened at $295.37 on Monday. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The firm has a market cap of $267.94 billion, a P/E ratio of 19.06, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business's 50 day moving average price is $452.40 and its 200 day moving average price is $503.72.</p>
<div class="lb-trans"><p>NYSE UNH 股票在週一開盤時為 295.37 美元。UnitedHealth Group Incorporated 的 52 周低點為 248.88 美元，52 周高點為 630.73 美元。該公司的市值為 2679.4 億美元，市盈率為 19.06，市盈增長比率為 1.37，貝塔係數為 0.56。該公司的速動比率為 0.91，流動比率為 0.83，債務與股本比率為 0.74。該業務的 50 日移動平均價格為 452.40 美元，200 日移動平均價格為 503.72 美元。</p>
</div><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter last year, the business earned $6.91 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.</p>
<div class="lb-trans"><p>UnitedHealth Group (NYSE:UNH - 獲取免費報告) 最近於 4 月 17 日星期四公佈了其財報。該醫療保健集團報告的每股收益 (EPS) 為 7.20 美元，低於分析師一致預期的 7.29 美元，差額為 0.09 美元。UnitedHealth Group 的淨利潤率為 3.60%，股本回報率為 26.69%。該業務的季度收入為 1,095.8 億美元，而分析師的預期為 1,115.6 億美元。去年同期，該業務的每股收益為 6.91 美元。平均而言，賣方分析師預計 UnitedHealth Group Incorporated 在當前年度將發佈 29.54 美元的每股收益。</p>
</div><h2>UnitedHealth Group Profile</h2>
<div class="lb-trans"><h2>UnitedHealth Group 簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p>
<div class="lb-trans"><p>聯合健康集團在美國作為一家多元化的醫療保健公司運營。該公司通過四個部門運營：聯合健康保險、Optum Health、Optum Insight 和 Optum Rx。聯合健康保險部門為國家僱主、公共部門僱主、中型僱主、小型企業和個人提供面向消費者的健康福利計劃和服務；為 50 歲及以上的個人提供醫療保險和健康與福祉服務，以滿足他們的需求；醫療補助計劃、兒童健康保險和醫療保健項目；以及健康和牙科福利、醫院和臨牀服務，以及為照顧經濟困難、醫療服務不足和沒有僱主資助醫療保險覆蓋的人羣的州項目提供的醫療保健福利產品和服務。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than UnitedHealth Group</li>
<li>Investing in Commodities: What Are They? How to Invest in Them</li>
<li>This Market Sell-Off Might Trigger a Value Rotation Into Pepsi</li>
<li>Compound Interest and Why It Matters When Investing</li>
<li>Alphabet Stock Lags—But Waymo May Be Its Hidden Driver</li>
<li>Low PE Growth Stocks: Unlocking Investment Opportunities</li>
<li>Trade Desk Silences Critics; Recovery Looks Poised to Continue</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過聯合健康集團</li>
<li>投資商品：它們是什麼？如何投資？</li>
<li>這次市場拋售可能會觸發對百事可樂的價值輪換</li>
<li>複利及其在投資中的重要性</li>
<li>字母表股票滯後——但 Waymo 可能是其隱藏的驅動因素</li>
<li>低市盈率成長股：解鎖投資機會</li>
<li>Trade Desk 駁斥批評；復甦看起來有望繼續</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=UNH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在聯合健康集團嗎？</h2>
</div><p>Before you consider UnitedHealth Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮聯合健康集團之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而聯合健康集團並不在名單上。</p>
</div><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然聯合健康集團目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Brucke Financial Inc. 對聯合健康集團公司（NYSE: UNH）進行了新的投資